EMERYVILLE, Calif., Jan. 20, 2021 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company centered on establishing and commercializing vaccines, these days announced that Kelly
Tag: Dynavax
Dynavax Appoints Kelly MacDonald as Chief Money Officer
“Michael’s contributions and unwavering determination to Dynavax have been important to the achievements of our enterprise. We are particularly fortuitous to have had his steerage